Clinical Trials
14 trialsNCT06051695 2026-05-26
EVEREST-2
A2 Biotherapeutics Inc.
Phase 1/2 Recruiting
NCT07604909 2026-05-22
A Phase II Randomized Trial of Serplulimab With Second-Line Chemo/Targeted Therapy for Early Relapse Colorectal Cancer After Adjuvant Chemotherapy
Fudan University
Phase 2 Recruiting
NCT07198945 2026-05-14
STARLING
Indiana University
Phase NA Not yet recruiting
NCT06434896 2026-05-12
CrEATE
UMC Utrecht
Phase NA Recruiting
NCT04337177 2026-05-11
Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors
Valent Technologies, LLC
Phase 1 Active not recruiting
NCT05283330 2026-04-30
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
Phase 1 Recruiting
NCT06475352 2026-04-23
FUDOSE
UNICANCER
Phase 2 Recruiting
NCT05861947 2026-04-17
JIVAN
Aurigene Discovery Technologies Limited
Phase 1 Terminated
NCT07277413 2026-04-03
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
IDEAYA Biosciences
Phase 1 Recruiting
NCT07494201 2026-03-27
MIMICC
Fondazione del Piemonte per l'Oncologia
Phase NA Recruiting
NCT06158139 2026-03-19
Autologous CAR-T Cells Targeting B7-H3 in PDAC
UNC Lineberger Comprehensive Cancer Center
Phase 1 Recruiting
NCT07221253 2026-03-17
AB02
AstraZeneca
Phase 3 Recruiting
NCT07224737 2026-03-13
EXOMIC
City of Hope Medical Center
Completed
NCT07448376 2026-03-04
EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases
Huazhong University of Science and Technology
Not yet recruiting